Atherosclerotic intracranial arterial stenosis: Risk factors, diagnosis, and treatment

The Lancet Neurology

Volumn 12, Issue 11, 2013, Pages 1106-1114

  Holmstedt, Christine A ^a   Turan, Tanya N ^a   Chimowitz, Marc I ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; C REACTIVE PROTEIN; CHOLESTEROL; CILOSTAZOL; CLOPIDOGREL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN A; PLASMINOGEN ACTIVATOR INHIBITOR 1; WARFARIN;

ANASTOMOSIS; ANTICOAGULANT THERAPY; ARTERY OCCLUSION; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; BYPASS SURGERY; CEREBROVASCULAR ACCIDENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONVENTIONAL ANGIOGRAPHY; DIABETES MELLITUS; ETHNIC GROUP; FOLLOW UP; FRACTIONAL FLOW RESERVE; GENETIC SUSCEPTIBILITY; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; INTRACRANIAL ATHEROSCLEROTIC STENOSIS; ISCHEMIC PRECONDITIONING; LACUNAR STROKE; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE CEREBRAL ARTERY OCCLUSION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVASCULARIZATION; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SMOKING; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK; VERTEBROBASILAR INSUFFICIENCY;

CEREBRAL ARTERIAL DISEASES; CONSTRICTION, PATHOLOGIC; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS;

EID: 84885350211     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(13)70195-9     Document Type: Review

References (91)

1. Gorelick PB, Wong KS, Bae HJ, Pandey DK Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke 2008, 39:2396-2399.
2. Sacco RL, Kargman DE, Gu Q, Zamanillo MC Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. Stroke 1995, 26:14-20. The Northern Manhattan Stroke Study.
3. Qureshi AI, Safdar K, Patel M, Janssen RS, Frankel MR Stroke in young black patients. Risk factors, subtypes, and prognosis. Stroke 1995, 26:1995-1998.
4. Weisberg LA Cl inical characteristics of transient ischemic attacks in black patients. Neurology 1991, 41:1410-1414.
5. Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 1996, 27:1974-1980.
6. Wong LK Global burden of intracranial atherosclerosis. Int J Stroke 2006, 1:158-159.
7. Kumar G, Kalita J, Kumar B, Bansal V, Jain SK, Misra U Magnetic resonance angiography findings in patients with ischemic stroke from north India. J Stroke Cerebrovasc Dis 2010, 19:146-152.
8. Moustafa RR, Moneim AA, Salem HH, Shalash AS, Azmy HA Intracranial steno-occlusive arterial disease and its associations in Egyptian ischemic stroke patients. Stroke 2013, 44:538-541.
9. Feldmann E, Daneault N, Kwan E, et al. Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology 1990, 40:1541-1545.
10. Gorelick PB, Caplan LR, Langenberg P, et al. Clinical and angiographic comparison of asymptomatic occlusive cerebrovascular disease. Neurology 1988, 38:852-858.
11. Williams AO, Resch JA, Loewenson RB Cerebral atherosclerosis-a comparative autopsy study between Nigerian Negroes and American Negroes and Caucasians. Neurology 1969, 19:205-210.
12. Arenillas JF, Molina CA, Chacon P, et al. High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis. Neurology 2004, 63:27-32.
13. Resch JA, Baker AB Etiologic mechanisms in cerebral atherosclerosis. Preliminary study of 3,839 cases. Arch Neurol 1964, 10:617-628.
14. Sacco RL, Kargman DE, Zamanillo MC Race-ethnic differences in stroke risk factors among hospitalized patients with cerebral infarction: the Northern Manhattan Stroke Study. Neurology 1995, 45:659-663.
15. Ingall TJ, Homer D, Baker HL, Kottke BA, O'Fallon WM, Whisnant JP Predictors of intracranial carotid artery atherosclerosis. Duration of cigarette smoking and hypertension are more powerful than serum lipid levels. Arch Neurol 1991, 48:687-691.
16. Rincon F, Sacco RL, Kranwinkel G, et al. Incidence and risk factors of intracranial atherosclerotic stroke: the Northern Manhattan Stroke Study. Cerebrovasc Dis 2009, 28:65-71.
17. Chaturvedi S, Turan TN, Lynn MJ, et al. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology 2007, 69:2063-2068.
18. Turan TN, Cotsonis G, Lynn MJ, Chaturvedi S, Chimowitz M Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation 2007, 115:2969-2975.
19. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005, 352:1305-1316.
20. Kim DE, Kim JY, Jeong SW, et al. Association between changes in lipid profiles and progression of symptomatic intracranial atherosclerotic stenosis: a prospective multicenter study. Stroke 2012, 43:1824-1830.
21. Ovbiagele B, Saver JL, Lynn MJ, Chimowitz M Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis. Neurology 2006, 66:1344-1349.
22. Bang OY, Kim JW, Lee JH, et al. Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology 2005, 65:296-298.
23. Bang OY, Saver JL, Ovbiagele B, Choi YJ, Yoon SR, Lee KH Adiponectin levels in patients with intracranial atherosclerosis. Neurology 2007, 68:1931-1937.
24. Massot A, Pelegri D, Penalba A, et al. Lipoprotein-associated phospholipase A2 testing usefulness among patients with symptomatic intracranial atherosclerotic disease. Atherosclerosis 2011, 218:181-187.
25. Arenillas JF, Alvarez-Sabin J, Molina CA, et al. Progression of symptomatic intracranial large artery atherosclerosis is associated with a proinflammatory state and impaired fibrinolysis. Stroke 2008, 39:1456-1463.
26. Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006, 113:555-563.
27. Liebeskind DS, Cotsonis GA, Saver JL, et al. Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol 2011, 69:963-974.
28. Lau AY, Wong EH, Wong A, Mok VC, Leung TW, Wong KS Significance of good collateral compensation in symptomatic intracranial atherosclerosis. Cerebrovasc Dis 2012, 33:517-524.
29. Caplan LR Intracranial branch atheromatous disease: a neglected, understudied, and underused concept. Neurology 1989, 39:1246-1250.
30. Caplan LR, Hennerici M Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 1998, 55:1475-1482.
31. Lee DK, Kim JS, Kwon SU, Yoo SH, Kang DW Lesion patterns and stroke mechanism in atherosclerotic middle cerebral artery disease: early diffusion-weighted imaging study. Stroke 2005, 36:2583-2588.
32. Schreiber S, Serdaroglu M, Schreiber F, Skalej M, Heinze HJ, Goertler M Simultaneous occurrence and interaction of hypoperfusion and embolism in a patient with severe middle cerebral artery stenosis. Stroke 2009, 40:e478-e480.
33. Caplan LR, Wong KS, Gao S, Hennerici MG Is hypoperfusion an important cause of strokes? If so, how?. Cerebrovasc Dis 2006, 21:145-153.
34. Khan A, Kasner SE, Lynn MJ, Chimowitz MI Risk factors and outcome of patients with symptomatic intracranial stenosis presenting with lacunar stroke. Stroke 2012, 43:1230-1233.
35. Feldmann E, Wilterdink JL, Kosinski A, et al. The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology 2007, 68:2099-2106.
36. Bash S, Villablanca JP, Jahan R, et al. Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography. AJNR Am J Neuroradiol 2005, 26:1012-1021.
37. Nguyen-Huynh MN, Wintermark M, English J, et al. How accurate is CT angiography in evaluating intracranial atherosclerotic disease?. Stroke 2008, 39:1184-1188.
38. Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 2000, 21:643-646.
39. Millikan CH, Siekert RG, Shick RM Studies in cerebrovascular disease. III. The use of anticoagulant drugs in the treatment of insufficiency or thrombosis within the basilar arterial system. Proc Staff Meet Mayo Clin 1955, 30:116-126.
40. Chimowitz MI, Kokkinos J, Strong J, et al. The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology 1995, 45:1488-1493.
41. Turan TN, Maidan L, Cotsonis G, et al. Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke 2009, 40:505-509.
42. Kasner SE, Lynn MJ, Chimowitz MI, et al. Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology 2006, 67:1275-1278.
43. The effectiveness of dual antiplatelet treatment in acute ischemic stroke patients with intracranial arterial stenosis: a subgroup analysis of CLAIR study. Int J Stroke 2012, The CLAIR study investigators, published online Aug 7. 10.1111/j.1747-4949.2012.00828.x.
44. Markus HS, Droste DW, Kaps M, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic carotid Stenosis (CARESS) trial. Circulation 2005, 111:2233-2240.
45. Wong KSL, Chen C, Fu J, et al. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol 2010, 9:489-497.
46. Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. New Engl J Med 2011, 365:993-1003.
47. Kwon SU, Cho YJ, Koo JS, et al. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke 2005, 36:782-786.
48. Kwon SU, Hong KS, Kang DW, et al. Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis. Stroke 2011, 42:2883-2890.
49. Amarenco P, Bogousslavsky J, Callahan A, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006, 355:549-559.
50. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001, 358:1033-1041. PROGRESS Collaborative Group.
51. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N Engl J Med 1985, 313:1191-1200. The EC/IC Bypass Study Group.
52. Bogousslavsky J, Barnett HJ, Fox AJ, Hachinski VC, Taylor W Atherosclerotic disease of the middle cerebral artery. Stroke 1986, 17:1112-1120.
53. Hopkins LN, Budny JL Complications of intracranial bypass for vertebrobasilar insufficiency. J Neurosurg 1989, 70:207-211.
54. Higashida RT, Tsai FY, Halbach VV, et al. Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. J Neurosurg 1993, 78:192-198.
55. Clark WM, Barnwell SL, Nesbit G, O'Neill OR, Wynn ML, Coull BM Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis. Stroke 1995, 26:1200-1204.
56. Touho H Percutaneous transluminal angioplasty in the treatment of atherosclerotic disease of the anterior cerebral circulation and hemodynamic evaluation. J Neurosurg 1995, 82:953-960.
57. Takis C, Kwan ES, Pessin MS, Jacobs DH, Caplan LR Intracranial angioplasty: experience and complications. AJNR Am J Neuroradiol 1997, 18:1661-1668.
58. Marks MP, Marcellus M, Norbash AM, Steinberg GK, Tong D, Albers GW Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke 1999, 30:1065-1069.
59. Connors JJ, Wojak JC Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg 1999, 91:415-423.
60. Nahser HC, Henkes H, Weber W, Berg-Dammer E, Yousry TA, Kuhne D Intracranial vertebrobasilar stenosis: angioplasty and follow-up. AJNR Am J Neuroradiol 2000, 21:1293-1301.
61. Alazzaz A, Thornton J, Aletich VA, Debrun GM, Ausman JI, Charbel F Intracranial percutaneous transluminal angioplasty for arteriosclerotic stenosis. Arch Neurol 2000, 57:1625-1630.
62. Gress DR, Smith WS, Dowd CF, Van Halbach V, Finley RJ, Higashida RT Angioplasty for intracranial symptomatic vertebrobasilar ischemia. Neurosurgery 2002, 51:23-27. discussion 27-29.
63. Gupta R, Schumacher HC, Mangla S, et al. Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis. Neurology 2003, 61:1729-1735.
64. Marks MP, Wojak JC, Al-Ali F, et al. Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke 2006, 37:1016-1020.
65. Marks MP, Marcellus ML, Do HM, et al. Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. AJNR Am J Neuroradiol 2005, 26:525-530.
66. Fiorella D, Turan TN, Derdeyn CP, Chimowitz MI Current status of the management of symptomatic intracranial atherosclerotic disease: the rationale for a randomized trial of medical therapy and intracranial stenting. J Neurointerv Surg 2009, 1:35-39.
67. Kessler IM, Mounayer C, Piotin M, Spelle L, Vanzin JR, Moret J The use of balloon-expandable stents in the management of intracranial arterial diseases: a 5-year single-center experience. AJNR Am J Neuroradiol 2005, 26:2342-2348.
68. Abruzzo TA, Tong FC, Waldrop AS, Workman MJ, Cloft HJ, Dion JE Basilar artery stent angioplasty for symptomatic intracranial athero-occlusive disease: complications and late midterm clinical outcomes. AJNR Am J Neuroradiol 2007, 28:808-815.
69. Fields JD, Petersen BD, Lutsep HL, et al. Drug eluting stents for symptomatic intracranial and vertebral artery stenosis. Interv Neuroradiol 2011, 17:241-247.
70. Park S, Lee DG, Chung WJ, Lee DH, Suh DC Long-term outcomes of drug-eluting stents in symptomatic intracranial stenosis. Neurointervention 2013, 8:9-14.
71. Bose A, Hartmann M, Henkes H, et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 2007, 38:1531-1537.
72. Zaidat OO, Klucznik R, Alexander MJ, et al. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology 2008, 70:1518-1524.
73. Fiorella D, Levy EI, Turk AS, et al. US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007, 38:881-887.
74. Fiorella D, Derdeyn CP, Lynn MJ, et al. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent stroke in Intracranial Stenosis (SAMMPRIS). Stroke 2012, 43:2682-2688.
75. Bliden KP, Dichiara J, Lawal L, et al. The association of cigarette smoking with enhanced platelet inhibition by clopidogrel. J Am Coll Cardiol 2008, 52:531-533.
76. Derdeyn CP, Fiorella D, Lynn MJ, et al. Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial. J Neurointerv Surg 2012, 0:1-6.
77. Wingspan Stent System, FDANeurologicalDevices Advisory Committee Meeting StrykerNeurovascular, (accessed Sept 11, 2013). http://www.fda/gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicaDevices/MedicalDevicesAdvisoryCommittee/NeurologicalDevicesPanel/UCM297341.pdf.
78. Zaidat OO, Castonguay AC, Fitzsimmons BF, et al. Design of the Vitesse Intracranial Stent Study for Ischemic Therapy (VISSIT) trial in symptomatic intracranial stenosis. J Stroke Cerebrovasc Dis 2012, published online Dec 21. 10.1016/j.jstrokecerebrovasdis.2012.10.021.
79. Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004, 364:331-337.
80. Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006, 354:1706-1717.
81. Amin-Hanjani S, Rose-Finnell L, Richardson D, et al. Vertebrobasilar flow Evaluation and Risk of Transient ischaemic Attack and Stroke study (VERiTAS): rationale and design. Int J Stroke 2010, 5:499-505.
82. Liebeskind DS, Kosinski AS, Lynn MJ, et al. Noninvasive fractional flow on MRA predicts stroke risk of intracranial stenosis in SONIA/WASID. Stroke 2013, 44. for the SONIA and WASID Investigators, (Abstract).
83. Swartz RH, Bhuta SS, Farb RI, et al. Intracranial arterial wall imaging using high-resolution 3-Tesla contrast-enhanced MRI. Neurology 2009, 72:627-634.
84. Ma N, Jiang WJ, Lou X, et al. Arterial remodeling of advanced basilar atherosclerosis: a 3-Tesla MRI study. Neurology 2010, 75:253-258.
85. Xu WH, Li ML, Gao S, et al. In vivo high-resolution MR imaging of symptomatic and asymptomatic middle cerebral artery atherosclerotic stenosis. Atherosclerosis 2010, 212:507-511.
86. Park JK, Kim SH, Kim BS, Choi G, Jeong SY, Choi JC Imaging of intracranial plaques with black-blood double inversion recovery MR imaging and CT. J Neuroimag 2011, 21:e64-e68.
87. Bodle JD, Feldmann E, Swartz RH, Rumboldt Z, Brown T, Turan TN High-resolution magnetic resonance imaging: an emerging tool for evaluating intracranial arterial disease. Stroke 2013, 44:287-292.
88. De Bruyne B, Pijls NH, Kalesan B, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 2012, 367:991-1001.
89. Dusick JR, Liebeskind DS, Saver JL, Martin NA, Gonzalez NR Indirect revascularization for nonmoyamoya intracranial arterial stenoses: clinical and angiographic outcomes. J Neurosurg 2012, 117:94-102.
90. Meng R, Asmaro K, Meng L, et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology 2012, 79:1853-1861.
91. Contractor T, Levin V, Martinez MW, Marchlinski FE Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: dawn of a new era. Postgrad Med 2013, 125:34-44.